BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6233773)

  • 1. T-cell reactions versus kidney cells, islets of Langerhans, and non-T lymphocytes.
    Roth D; Russell T; Fuller L; Kyriakides GK; Mintz D; Miller J
    Transplant Proc; 1984 Jun; 16(3):854-6. PubMed ID: 6233773
    [No Abstract]   [Full Text] [Related]  

  • 2. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of the human mixed lymphocyte islet coculture.
    Swift SM; Rose SH; London NJ; James RF
    Transplant Proc; 1994 Apr; 26(2):732. PubMed ID: 8171630
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of distinct domains of Ia antigens in autologous and allogeneic mixed lymphocyte reactions.
    Indiveri F; Scudeletti M; Pende D; Barabino A; Russo C; Pellegrino MA; Ferrone S
    Behring Inst Mitt; 1983 May; (72):95-100. PubMed ID: 6242347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of primate islets with anti-class II antibodies and complement fails to deplete class II-bearing cells.
    Flynn GJ; Leow CK; Sutton RS; Gray DW; Morris PJ
    Transplant Proc; 1990 Apr; 22(2):786-8. PubMed ID: 2109402
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous reactive T cell clones and T-T hybrids.
    Richardson B; Stobo JD
    Behring Inst Mitt; 1983 May; (72):87-8. PubMed ID: 6242345
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporin A prevents the appearance of cell surface "activation" antigens.
    Leapman SB; Strong DM; Filo RS; Smith EJ; Brandt GL
    Transplantation; 1982 Aug; 34(2):94-5. PubMed ID: 6215747
    [No Abstract]   [Full Text] [Related]  

  • 8. Significant manipulative procedures to reduce immunogenicity of human islet allografts.
    Ulrichs K; Müller-Ruchholtz W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2727. PubMed ID: 2523162
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and viability of alpha-class II immunotoxin-treated pig islet cells.
    Mullen Y; Shiogama T; Ozawa A; Leonard JE; Papoian T; Tsunoda T; Terada M; Motojima K; Brown J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):934-6. PubMed ID: 2978886
    [No Abstract]   [Full Text] [Related]  

  • 10. Responses of canine lymphocytes to allogeneic and autologous Islets of Langerhans in mixed cell cultures.
    Miller J; Rabinovitch A; Fuller L; Kyriakides G; Severyn W; Noel J; Flaa C; Mintz D
    Transplant Proc; 1981 Mar; 13(1 Pt 2):807-9. PubMed ID: 6455825
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-DR on T and non-T mononuclear leukocytes.
    J Exp Med; 1980 Aug; 152(2 Pt 2):137s-139s. PubMed ID: 6447742
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic monoclonal antibodies for in vitro immunomodulation of dog islets.
    Brons IG; Tavora PF; Cobbold SP; Davies HS; Waldmann H; Calne RY
    Transplant Proc; 1992 Jun; 24(3):1032-3. PubMed ID: 1534944
    [No Abstract]   [Full Text] [Related]  

  • 13. The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes.
    Stock PG; Ascher NL; Chen S; Bumgardner G; Field MJ; Sutherland DE
    Transplant Proc; 1990 Apr; 22(2):841-3. PubMed ID: 2183451
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct and indirect recognition of pig class II antigens by human T cells.
    Yamada K; Sachs DH; DerSimonian H
    Transplant Proc; 1995 Feb; 27(1):258-9. PubMed ID: 7878993
    [No Abstract]   [Full Text] [Related]  

  • 15. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
    Shen HH; Irigoyen O; Friedman SM; Chess L
    J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed lymphocyte kidney and islet cell cocultures: the effect of IFN-gamma and anti-IFN-gamma.
    Fernandez J; Asthana D; Zucker K; Lu P; Fuller L; Yang WC; Esquenazi V; Carreno M; Roth D; Burke GW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):117-9. PubMed ID: 8438245
    [No Abstract]   [Full Text] [Related]  

  • 18. Ia-bearing cells within isolated canine islets.
    Gebel HM; Yasunami Y; Diekgraefe B; Davie JM; Lacy PE
    Transplantation; 1983 Sep; 36(3):346-8. PubMed ID: 6412406
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-V beta TcR monoclonal antibodies identify and can activate anergic T cells from mice rendered neonatally tolerant of class II alloantigens.
    Levy RB; Jones M; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):360-1. PubMed ID: 8438335
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavior of HLA-DR homozygous cells in MLC and PLT.
    Zier KS; Gansbacher B; Scholz S; Albert E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1035-8. PubMed ID: 6168061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.